# Glucose Risk Assessment in Employer Populations

> **NCT04529824** · — · COMPLETED · sponsor: **DexCom, Inc.** · enrollment: 207 (actual)

## Conditions studied

- Diabetes
- Pre-diabetes
- Glucose Intolerance

## Interventions

- **DEVICE:** Dexcom G6 Continuous Glucose Monitor (CGM) System

## Key facts

- **NCT ID:** NCT04529824
- **Lead sponsor:** DexCom, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2019-07-22
- **Final completion:** 2021-08-01
- **Target enrollment:** 207 (ACTUAL)
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04529824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04529824, "Glucose Risk Assessment in Employer Populations". Retrieved via AI Analytics 2026-06-11 from https://api.ai-analytics.org/clinical/NCT04529824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
